Negotiating equitable distribution of COVID-19 vaccines globally with Derrick Sim
Please join us as we welcome Derrick Sim for a fireside chat on Thursday 28 April, from 5pm.
Derrick’s work throughout the pandemic has been critical in improving both vaccine supply and access, particularly to those in developing nations. As the Director of Vaccine Supply & Demand at Gavi, and as a member of the leadership team at COVAX, Derrick has led deals and negotiations with vaccine manufacturers for over 3 billion doses of covid vaccines supplied to over 140 countries.
During the event we will hear how Gavi developed the largest COVID-19 vaccine portfolio globally and discover how Gavi are creating affordable and accessible vaccines, navigating complexities such as agreements between public and private stakeholders. As an MBS alumnus, find out which learnings from his MBA have helped Derrick achieve these tremendous outcomes, and the tools which have helped him the most.
About our speaker
Derrick Sim is the Director of Vaccine Supply & Demand at Gavi, the Vaccines Alliance in Geneva.
He leads the COVAX Facility’s Deals and Transactions Team to secure COVID-19 vaccines for their equitable distribution globally. Over a billion doses of these vaccines have now been delivered to over 140 countries globally.
He has over 18 years’ experience in the vaccines industry having managed their commercialization, launch and development at global and regional levels. Prior to Gavi, he led GlaxoSmithKline’s global pneumococcal and rotavirus vaccines businesses from London and Brussels. He has experience working with policy makers and governments, including those in the Asia Pacific region during the 2009 H1N1 influenza pandemic, on their national vaccine programmes. His understanding of the challenges faced by low- and middle-income communities in accessing health care has been shaped by several years in Manila where he introduced several initiatives to increase access as head of GlaxoSmithKline’s vaccines business. Derrick also contributed to the launch of the HPV cervical cancer vaccine and phase 3 clinical development and licensure of the rotavirus vaccine while leading the Asia Pacific regional medical affairs in Singapore.
Derrick began his professional life at the Royal Children’s Hospital in Melbourne as a medical doctor, where his interest in vaccines was ignited after being involved in phase 2 and 3 clinical research at the Murdoch Children’s Research Institute, and holds an MBA from the Melbourne Business School, Australia.